Clinical Trials

Showing 101 - 120 of 513 trials
Title Investigatorsort icon Disease(s)
A Phase II Study of MPDL3280A in Patients with Locally Advanced or Metastatic Urothelial Bladder Cancer
[Protocol 14-090]
Rosenberg, Jonathan
  • Bladder Cancer
A Phase III Study of Gemcitabine and Cisplatin with and without Bevacizumab in Patients with Advanced Transitional Cell Carcinoma
[Protocol 12-119]
Rosenberg, Jonathan
  • Bladder Cancer
  • Kidney Cancer
A Phase II Study of Docetaxel Alone or with OGX-427 in Patients with Recurrent or Refractory Urothelial Cancers
Relapsed/Refractory
[Protocol 13-127]
Rosenberg, Jonathan
  • Bladder Cancer
  • Kidney Cancer
A Phase I Study of ASG-22CE in Patients with Metastatic Urothelial Cancers Containing Nectin-4
[Protocol 14-108]
Rosenberg, Jonathan
  • Bladder Cancer
A Phase III Study of Olaparib versus Standard Chemotherapy to Treat Patients with Metastatic Breast Cancer Who Have BRCA Mutations
[Protocol 14-157]
Robson, Mark
  • Breast Cancer
Understanding Decision-Making Processes for Undergoing Genetic Testing Among Women with Newly Diagnosed Breast Cancer
[Protocol 11-086]
Robson, Mark
  • Breast Cancer
  • Hereditary Cancer & Genetics
A Phase II Study of Veliparib plus Temozolomide, Veliparib plus Carboplatin and Paclitaxel, or Carboplatin and Paclitaxel with Placebo in Patients with BRCA Mutations and Metastatic Breast Cancer
[Protocol 12-122]
Robson, Mark
  • Breast Cancer
A Phase I Study of Difluoromethylornithine and Celecoxib with Cyclophosphamide and Topotecan in Patients with Recurrent or Persistent Neuroblastoma
Relapsed/Refractory
[Protocol 14-187]
Roberts, Stephen
  • Neuroblastoma
A Phase I Study of Humanized 3F8 plus Interleukin-2 in Patients with High-Risk Neuroblastoma and GD2-Positive Tumors
Relapsed/Refractory
[Protocol 12-116]
Roberts, Stephen
  • Neuroblastoma
  • Sarcomas
    • Osteosarcoma
    • Soft Tissue Sarcoma
A Phase II Study of MEDI4736 in Patients with Stage IIIB-IV Non-Small Cell Lung Cancer Containing the PD-L1 Protein
[Protocol 14-103]
Rizvi, Naiyer
  • Lung Cancer, Non-Small Cell
A Phase I Study of Nivolumab with Combination Chemotherapy for Patients with Previously Untreated Stage IIIB or IV Non-Small Cell Lung Cancer
[Protocol 11-189]
Rizvi, Naiyer
  • Lung Cancer
  • Lung Cancer, Non-Small Cell
    • Lung Adenocarcinoma
A Phase I Study Assessing the Immunomodulatory Activity of LY2157299 in Patients with Advanced Solid Tumors
[Protocol 14-117]
Rizvi, Naiyer
  • Solid Tumors
A Phase I Study of BMS-986015 with Ipilimumab in Patients with Advanced Non-Small Cell Lung Cancer, Prostate Cancer, or Melanoma
[Protocol 12-283]
Rizvi, Naiyer
  • Lung Cancer, Non-Small Cell
  • Melanoma
  • Prostate Cancer
    • Metastatic Disease after Hormone-Reducing Therapy
  • Solid Tumors
A Phase Ib Study of Tremelimumab and MEDI4736 in Patients with Advanced Non-Small Cell Lung Cancer
[Protocol 13-197]
Rizvi, Naiyer
  • Lung Cancer, Non-Small Cell
A Prospective Clinical Trial to Evaluate Mesothelin as a Biomarker for the Clinical Management of Esophageal Cancer
[Protocol 11-037]
Rizk, Nabil
  • Esophageal Disorders
    • Barrett's Esophagus
  • Upper Gastrointestinal
    • Esophageal Cancer
A Study to See if Mesothelin Can Serve as a Marker of Early Lung Cancer
Newly Diagnosed
[Protocol 13-262]
Rizk, Nabil
  • Lung Cancer, Non-Small Cell
    • Lung Adenocarcinoma
Calypso-Based Deep Inspiration Breath Hold Radiation Treatment for Lung Cancer
[Protocol 13-174]
Rimner, Andreas
  • Lung Cancer
A Study Assessing the Predictive Value of Tumor Hypoxia (Low Oxygen Supply) in Patients with Non-Small Cell Lung Cancer
[Protocol 13-186]
Rimner, Andreas
  • Lung Cancer, Non-Small Cell
A Phase I Study of Stereotactic Body Radiation Therapy for Inoperable Locally Advanced Non-Small Cell Lung Cancer
Newly Diagnosed
[Protocol 13-113]
Rimner, Andreas
  • Lung Cancer, Non-Small Cell
A Phase III Comparison of Thoracic Radiotherapy Regimens in Patients with Limited Small Cell Lung Cancer also Receiving Cisplatin and Etoposide
[Protocol 11-003]
Rimner, Andreas
  • Lung Cancer
  • Lung Cancer, Small Cell
    • Other